Product Description
Learning Outcomes:
6a Understand where patients can apply these to the HTA process and formulary decision in their country
6b Outline the difference between quantitative and qualitative research
6c Understand the role each type of research plays in HTA
6d Understand the principles, practical application and importance of patient reported outcomes in developing the evidence
6e Understand how this additional evidence can be used in HTA processes
6K Understand what ‘good’ economic evaluation looks like
6L Understand what ‘good; ethical, legal and social implications (ELSI) analysis looks like
6M Locate key reference sources for comparing features of health system reimbursement
6N Comparisons across two systems
6O Understand what type of information contributes to a better understanding of clinical benefit (e.g., randomized trials)
6P Understand differences in clinical information requirements for patients, payers, and regulators
6Q Understand rigorous methods for identifying and combining information (e.g., systematic review and meta-analysis)
6R Understand the strengths and weaknesses of methods to combine data
6S Identify the main HTA agencies in Europe
6T Understand their different approaches to evaluating medicine and health technologies
6U Understand the role of evidence-based medicine and how this relates to HTA in European agencies
6V Describe specific opportunities for patients in key agencies across Europe
6W Describe the concepts of quality of life, health-related quality of life, and patient-relevant outcomes
6X Understand how these are measured
6Y Describe how these can be incorporated into HTA assessments
6Z Understand the principles, practical application and importance of patient reported outcomes in developing the evidence for
Reviews
There are no reviews yet.